Univariate and multivariate analysis for remission duration (evaluable patients)
| Prognostic factor . | Univariate . | Multivariate . | ||
|---|---|---|---|---|
| P-value . | N . | Risk ratio . | P-value . | |
| Age (y)6-150 | .2987 | |||
| < 45 | ||||
| > 45 | ||||
| Baseline WBC (cells/μL)6-150 | .2933 | |||
| < 5000 | ||||
| > 5000 | ||||
| Sex | .6741 | |||
| Female | ||||
| Male | ||||
| Relapse status group | .0153 | 38 | 2.42 | .0153 |
| Newly diagnosed | ||||
| Relapse (group 1) | ||||
| Relapse (group 2) | ||||
| Prior oral ATRA | .1741 | |||
| No | ||||
| Yes | ||||
| Prior ATRA syndrome | .0063 | |||
| No | ||||
| Yes | ||||
| Current ATRA syndrome | .9923 | |||
| No | ||||
| Yes | ||||
| Baseline performance status | .1750 | |||
| Intubation | .9928 | |||
| No | ||||
| Yes | ||||
| DIC | .0465 | |||
| No | ||||
| Yes | ||||
| Prognostic factor . | Univariate . | Multivariate . | ||
|---|---|---|---|---|
| P-value . | N . | Risk ratio . | P-value . | |
| Age (y)6-150 | .2987 | |||
| < 45 | ||||
| > 45 | ||||
| Baseline WBC (cells/μL)6-150 | .2933 | |||
| < 5000 | ||||
| > 5000 | ||||
| Sex | .6741 | |||
| Female | ||||
| Male | ||||
| Relapse status group | .0153 | 38 | 2.42 | .0153 |
| Newly diagnosed | ||||
| Relapse (group 1) | ||||
| Relapse (group 2) | ||||
| Prior oral ATRA | .1741 | |||
| No | ||||
| Yes | ||||
| Prior ATRA syndrome | .0063 | |||
| No | ||||
| Yes | ||||
| Current ATRA syndrome | .9923 | |||
| No | ||||
| Yes | ||||
| Baseline performance status | .1750 | |||
| Intubation | .9928 | |||
| No | ||||
| Yes | ||||
| DIC | .0465 | |||
| No | ||||
| Yes | ||||
See Table 5 for abbreviations.
Age as a continuous parameter P = .2453; WBC as a continuous parameter P = .3126.